Expression of alpha-1-antichymotrypsin in prostate carcinoma

Nam Hoon Cho, Chanil Park, Dong Soo Park

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Prostate specific antigen (PSA) is a glycoprotein with the enzymatic activity of serine protease, the gene which is encoded in the human glandular kallikrein gene locus. Catalytically active PSA released into serum may be inactivated by a complex formation with α1ACT (ACT) and α2MG (MG), two major protease inhibitors. The serum complex-to-total PSA ratio can be used as a marker for the differentiation between prostate carcinoma (PCa) and a benign lesion because of a significant elevation of PSA binding to ACT in PCa. Apparently higher immunohistochemical expressions of PSA and ACT have been reported in PCa of low Gleason scores when compared with benign lesions. The fact that only normal secretory epitheliums are capable of producing ACT was recently proved by immunohistochemical and in situ hybridization methods. Our immunohistochemical study of ACT showed a tendency toward stronger expression in high Gleason grade PCa than in low Gleason grade PCa. Prostate intraepithelial neoplasia (PIN), as well as BPH, seldom react to ACT. Expression of ACT in normal ducts or acini was influenced by their location. In a normal prostate, expression of ACT was predominantly in secretory epithelial cells, with a minority of basal cells and rarely in the interdigitating neuroendocrine cells. Whereas the potency of ACT production in epithelial cells almost always appeared to be suppressed under normal conditions, it was noted that a strong expression of ACT was apparent in the normal ducts or acini near a high grade carcinoma with a weak reaction to ACT. ACT expression is much more enhanced in high grade carcinomas and in the residual normal acini adjacent to carcinomas of low ACT expression, presumably representing scale down the elevated PSA.

Original languageEnglish
Pages (from-to)228-233
Number of pages6
JournalJournal of Korean medical science
Volume12
Issue number3
DOIs
Publication statusPublished - 1997 Jan 1

Fingerprint

alpha 1-Antichymotrypsin
Prostate-Specific Antigen
Prostate
Carcinoma
Epithelial Cells
Tissue Kallikreins
Neuroendocrine Cells
Neoplasm Grading
Differentiation Antigens
Carcinoma in Situ
Serine Proteases
Protease Inhibitors
Serum
Dendritic Cells
Genes
In Situ Hybridization
Glycoproteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Cho, Nam Hoon ; Park, Chanil ; Park, Dong Soo. / Expression of alpha-1-antichymotrypsin in prostate carcinoma. In: Journal of Korean medical science. 1997 ; Vol. 12, No. 3. pp. 228-233.
@article{ab29446cc70148bab4a58d00b12632b2,
title = "Expression of alpha-1-antichymotrypsin in prostate carcinoma",
abstract = "Prostate specific antigen (PSA) is a glycoprotein with the enzymatic activity of serine protease, the gene which is encoded in the human glandular kallikrein gene locus. Catalytically active PSA released into serum may be inactivated by a complex formation with α1ACT (ACT) and α2MG (MG), two major protease inhibitors. The serum complex-to-total PSA ratio can be used as a marker for the differentiation between prostate carcinoma (PCa) and a benign lesion because of a significant elevation of PSA binding to ACT in PCa. Apparently higher immunohistochemical expressions of PSA and ACT have been reported in PCa of low Gleason scores when compared with benign lesions. The fact that only normal secretory epitheliums are capable of producing ACT was recently proved by immunohistochemical and in situ hybridization methods. Our immunohistochemical study of ACT showed a tendency toward stronger expression in high Gleason grade PCa than in low Gleason grade PCa. Prostate intraepithelial neoplasia (PIN), as well as BPH, seldom react to ACT. Expression of ACT in normal ducts or acini was influenced by their location. In a normal prostate, expression of ACT was predominantly in secretory epithelial cells, with a minority of basal cells and rarely in the interdigitating neuroendocrine cells. Whereas the potency of ACT production in epithelial cells almost always appeared to be suppressed under normal conditions, it was noted that a strong expression of ACT was apparent in the normal ducts or acini near a high grade carcinoma with a weak reaction to ACT. ACT expression is much more enhanced in high grade carcinomas and in the residual normal acini adjacent to carcinomas of low ACT expression, presumably representing scale down the elevated PSA.",
author = "Cho, {Nam Hoon} and Chanil Park and Park, {Dong Soo}",
year = "1997",
month = "1",
day = "1",
doi = "10.3346/jkms.1997.12.3.228",
language = "English",
volume = "12",
pages = "228--233",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "3",

}

Expression of alpha-1-antichymotrypsin in prostate carcinoma. / Cho, Nam Hoon; Park, Chanil; Park, Dong Soo.

In: Journal of Korean medical science, Vol. 12, No. 3, 01.01.1997, p. 228-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of alpha-1-antichymotrypsin in prostate carcinoma

AU - Cho, Nam Hoon

AU - Park, Chanil

AU - Park, Dong Soo

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Prostate specific antigen (PSA) is a glycoprotein with the enzymatic activity of serine protease, the gene which is encoded in the human glandular kallikrein gene locus. Catalytically active PSA released into serum may be inactivated by a complex formation with α1ACT (ACT) and α2MG (MG), two major protease inhibitors. The serum complex-to-total PSA ratio can be used as a marker for the differentiation between prostate carcinoma (PCa) and a benign lesion because of a significant elevation of PSA binding to ACT in PCa. Apparently higher immunohistochemical expressions of PSA and ACT have been reported in PCa of low Gleason scores when compared with benign lesions. The fact that only normal secretory epitheliums are capable of producing ACT was recently proved by immunohistochemical and in situ hybridization methods. Our immunohistochemical study of ACT showed a tendency toward stronger expression in high Gleason grade PCa than in low Gleason grade PCa. Prostate intraepithelial neoplasia (PIN), as well as BPH, seldom react to ACT. Expression of ACT in normal ducts or acini was influenced by their location. In a normal prostate, expression of ACT was predominantly in secretory epithelial cells, with a minority of basal cells and rarely in the interdigitating neuroendocrine cells. Whereas the potency of ACT production in epithelial cells almost always appeared to be suppressed under normal conditions, it was noted that a strong expression of ACT was apparent in the normal ducts or acini near a high grade carcinoma with a weak reaction to ACT. ACT expression is much more enhanced in high grade carcinomas and in the residual normal acini adjacent to carcinomas of low ACT expression, presumably representing scale down the elevated PSA.

AB - Prostate specific antigen (PSA) is a glycoprotein with the enzymatic activity of serine protease, the gene which is encoded in the human glandular kallikrein gene locus. Catalytically active PSA released into serum may be inactivated by a complex formation with α1ACT (ACT) and α2MG (MG), two major protease inhibitors. The serum complex-to-total PSA ratio can be used as a marker for the differentiation between prostate carcinoma (PCa) and a benign lesion because of a significant elevation of PSA binding to ACT in PCa. Apparently higher immunohistochemical expressions of PSA and ACT have been reported in PCa of low Gleason scores when compared with benign lesions. The fact that only normal secretory epitheliums are capable of producing ACT was recently proved by immunohistochemical and in situ hybridization methods. Our immunohistochemical study of ACT showed a tendency toward stronger expression in high Gleason grade PCa than in low Gleason grade PCa. Prostate intraepithelial neoplasia (PIN), as well as BPH, seldom react to ACT. Expression of ACT in normal ducts or acini was influenced by their location. In a normal prostate, expression of ACT was predominantly in secretory epithelial cells, with a minority of basal cells and rarely in the interdigitating neuroendocrine cells. Whereas the potency of ACT production in epithelial cells almost always appeared to be suppressed under normal conditions, it was noted that a strong expression of ACT was apparent in the normal ducts or acini near a high grade carcinoma with a weak reaction to ACT. ACT expression is much more enhanced in high grade carcinomas and in the residual normal acini adjacent to carcinomas of low ACT expression, presumably representing scale down the elevated PSA.

UR - http://www.scopus.com/inward/record.url?scp=0031159781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031159781&partnerID=8YFLogxK

U2 - 10.3346/jkms.1997.12.3.228

DO - 10.3346/jkms.1997.12.3.228

M3 - Article

C2 - 9250919

AN - SCOPUS:0031159781

VL - 12

SP - 228

EP - 233

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 3

ER -